Your session is about to expire
← Back to Search
MRI After Radiosurgery for Brain Cancer
N/A
Recruiting
Led By Scott Floyd, M.D. Ph.D.
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Radiographic progression on post-SRS imaging at previously treated SRS site(s)
Patients must have been diagnosed with a metastatic solid tumor of any histological type except small cell lung cancer (SCLC), or lymphoma
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
Study Summary
This trial will test whether adding an MRI sequence can help doctors better distinguish between radiation damage and tumor recurrence in patients who have had brain radiation surgery.
Who is the study for?
This trial is for adults over 18 with brain metastasis from solid tumors, excluding small cell lung cancer and lymphoma, who've had stereotactic radiosurgery (SRS). They must be candidates for brain surgery, able to undergo MRI with contrast, and have signed an informed consent.Check my eligibility
What is being tested?
The study is testing if adding another sequence to the MRI scan can better differentiate between tumor regrowth and radiation damage in patients who've undergone SRS for brain metastases.See study design
What are the potential side effects?
Since this trial involves only additional MRI imaging sequences without new drugs or invasive procedures, side effects are minimal but may include discomfort during the scan or reactions to contrast agents used.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My cancer has grown at the site previously treated with radiation.
Select...
I have been diagnosed with a metastatic cancer that is not small cell lung cancer or lymphoma.
Select...
I am 18 years old or older.
Select...
I have cancer that has spread to my brain and was treated with radiation.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
number of negative MRI sequences along with negative tumor biopsies
number of positive MRI sequences along with positive tumor biopsies
Trial Design
1Treatment groups
Experimental Treatment
Group I: MRIExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Duke UniversityLead Sponsor
2,363 Previous Clinical Trials
3,420,449 Total Patients Enrolled
Scott Floyd, M.D. Ph.D.Principal InvestigatorDuke Health
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot have an MRI with contrast due to a medical condition or allergy.My cancer has grown at the site previously treated with radiation.I have been diagnosed with a metastatic cancer that is not small cell lung cancer or lymphoma.My doctors have decided surgery is too risky for me.I am 18 years old or older.I am considered suitable for brain surgery by my neurosurgeon and anesthesia team.My cancer is either small cell lung cancer or lymphoma.I have cancer that has spread to my brain and was treated with radiation.I may have had brain radiation for cancer spread but it's not a must for this study.
Research Study Groups:
This trial has the following groups:- Group 1: MRI
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any openings for participants in this experiment?
"That is correct. Upon reviewing the data on clinicaltrials.gov, it's evident that this trial began recruiting subjects in July 2021 and was recently updated in July 2022. There exists a need for 37 individuals at 1 medical centre to complete the study."
Answered by AI
How many people are being monitored for this experiment?
"Affirmative. According to information on clinicaltrials.gov, the trial which was initially posted on July 19th 2021 is currently recruiting candidates. A total of 37 patients are needed from one medical centre."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger